Home/Filings/4/0000899243-21-010812
4//SEC Filing

LEWIS JOSEPH 4

Accession 0000899243-21-010812

CIK 0001576263other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 9:48 PM ET

Size

31.4 KB

Accession

0000899243-21-010812

Insider Transaction Report

Form 4
Period: 2021-03-05
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+597,444$5972,363,004 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh363,000$65,757,4502,000,000 total
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+13,996$14267,334 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh37,000$6,702,550230,333 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh4$7242,363,000 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh13,996$78,3640 total
    Exercise: $0.00From: 2017-01-06Common Stock (13,996 underlying)
  • Sale

    Common Stock

    2021-03-05$181.00/sh1$181267,333 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$13.00/sh468,639$6,091,838332,809 total
    Exercise: $0.00From: 2017-11-20Common Stock (468,639 underlying)
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh128,805$721,1790 total
    Exercise: $0.00From: 2017-01-06Common Stock (128,805 underlying)
LEWIS JOSEPH
10% Owner
Transactions
  • Sale

    Common Stock

    2021-03-05$181.00/sh1$181267,333 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh13,996$78,3640 total
    Exercise: $0.00From: 2017-01-06Common Stock (13,996 underlying)
  • Sale

    Common Stock

    2021-03-05$181.15/sh37,000$6,702,550230,333 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh4$7242,363,000 total
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+597,444$5972,363,004 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh363,000$65,757,4502,000,000 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh128,805$721,1790 total
    Exercise: $0.00From: 2017-01-06Common Stock (128,805 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+13,996$14267,334 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$13.00/sh468,639$6,091,838332,809 total
    Exercise: $0.00From: 2017-11-20Common Stock (468,639 underlying)
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+13,996$14267,334 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh128,805$721,1790 total
    Exercise: $0.00From: 2017-01-06Common Stock (128,805 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+597,444$5972,363,004 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh1$181267,333 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh363,000$65,757,4502,000,000 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh37,000$6,702,550230,333 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh13,996$78,3640 total
    Exercise: $0.00From: 2017-01-06Common Stock (13,996 underlying)
  • Sale

    Common Stock

    2021-03-05$181.00/sh4$7242,363,000 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$13.00/sh468,639$6,091,838332,809 total
    Exercise: $0.00From: 2017-11-20Common Stock (468,639 underlying)
Transactions
  • Sale

    Common Stock

    2021-03-05$181.15/sh37,000$6,702,550230,333 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh363,000$65,757,4502,000,000 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh128,805$721,1790 total
    Exercise: $0.00From: 2017-01-06Common Stock (128,805 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+597,444$5972,363,004 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh13,996$78,3640 total
    Exercise: $0.00From: 2017-01-06Common Stock (13,996 underlying)
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$13.00/sh468,639$6,091,838332,809 total
    Exercise: $0.00From: 2017-11-20Common Stock (468,639 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+13,996$14267,334 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh4$7242,363,000 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh1$181267,333 total
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+13,996$14267,334 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh4$7242,363,000 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh1$181267,333 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh37,000$6,702,550230,333 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh363,000$65,757,4502,000,000 total
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+597,444$5972,363,004 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh128,805$721,1790 total
    Exercise: $0.00From: 2017-01-06Common Stock (128,805 underlying)
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh13,996$78,3640 total
    Exercise: $0.00From: 2017-01-06Common Stock (13,996 underlying)
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$13.00/sh468,639$6,091,838332,809 total
    Exercise: $0.00From: 2017-11-20Common Stock (468,639 underlying)
Transactions
  • Sale

    Common Stock

    2021-03-05$181.15/sh37,000$6,702,550230,333 total
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+597,444$5972,363,004 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh363,000$65,757,4502,000,000 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh4$7242,363,000 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh1$181267,333 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh128,805$721,1790 total
    Exercise: $0.00From: 2017-01-06Common Stock (128,805 underlying)
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh13,996$78,3640 total
    Exercise: $0.00From: 2017-01-06Common Stock (13,996 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+13,996$14267,334 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$13.00/sh468,639$6,091,838332,809 total
    Exercise: $0.00From: 2017-11-20Common Stock (468,639 underlying)
Transactions
  • Sale

    Common Stock

    2021-03-05$181.00/sh1$181267,333 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh4$7242,363,000 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh13,996$78,3640 total
    Exercise: $0.00From: 2017-01-06Common Stock (13,996 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+13,996$14267,334 total
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+597,444$5972,363,004 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh128,805$721,1790 total
    Exercise: $0.00From: 2017-01-06Common Stock (128,805 underlying)
  • Sale

    Common Stock

    2021-03-05$181.15/sh37,000$6,702,550230,333 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh363,000$65,757,4502,000,000 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$13.00/sh468,639$6,091,838332,809 total
    Exercise: $0.00From: 2017-11-20Common Stock (468,639 underlying)
Transactions
  • Sale

    Common Stock

    2021-03-05$181.15/sh37,000$6,702,550230,333 total
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+13,996$14267,334 total
  • Sale

    Common Stock

    2021-03-05$181.15/sh363,000$65,757,4502,000,000 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh13,996$78,3640 total
    Exercise: $0.00From: 2017-01-06Common Stock (13,996 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-05$0.00/sh+597,444$5972,363,004 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$5.60/sh128,805$721,1790 total
    Exercise: $0.00From: 2017-01-06Common Stock (128,805 underlying)
  • Sale

    Common Stock

    2021-03-05$181.00/sh1$181267,333 total
  • Sale

    Common Stock

    2021-03-05$181.00/sh4$7242,363,000 total
  • Exercise/Conversion

    Warrant (right to purchase)

    2021-03-05$13.00/sh468,639$6,091,838332,809 total
    Exercise: $0.00From: 2017-11-20Common Stock (468,639 underlying)
Footnotes (4)
  • [F1]These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
  • [F2]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. ("Braslyn"), (ii) Boxer Capital, LLC ("Boxer Capital") (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) MVA Investors, LLC ("MVA Investors"), (v) Lockend Five, LLC ("Lockend Five"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the "Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital.
  • [F3](Continued from Footnote 2) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
  • [F4]The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001015747

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 9:48 PM ET
Size
31.4 KB